Subjects with Alzheimer's disease (AD) may have low levels of circulating lactate and pyruvate but normal plasma ketone bodies (KBs, b-hydroxybutyrate and acetoacetate). In this paper, we point out the underlying mechanisms for the above findings. Low lactate and pyruvate may be accounted for by abnormalities in glycolytic and aerobic pathways, such as reduced glycogen store and/or decreased levels of glucose transport, decreased phosphofructokinase activity, and increases in oxidatively modified glycolytic enzymes. The fact that patients had normal levels of KBs suggests that they were not starving and that their dietary intakes were normal. There are potentially two negative practical consequences of these metabolic abnormalities: reduced...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by amyloid plaques that are co...
Subjects with Alzheimer's disease (AD) may have low levels of circulating lactate and pyruvate but n...
In Alzheimer's disease (AD), the presence of amyloid-ii peptide may impair cell energy formation by ...
In Alzheimer's disease (AD), the presence of amyloid-ii peptide may impair cell energy formation by ...
Increasing evidence indicates that mitochondrial dysfunction occurs in the central nervous system as...
Increasing evidence indicates that mitochondrial dysfunction occurs in the central nervous system as...
Mitochondrial dysfunction is pivotal in the development of neurodegenerative dementias, causing cell...
Mitochondrial dysfunction is pivotal in the development of neurodegenerative dementias, causing cell...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
Mitochondrial dysfunction is pivotal in the development of neurodegenerative dementias, causing cell...
Mitochondrial dysfunction is pivotal in the development of neurodegenerative dementias, causing cell...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by amyloid plaques that are co...
Subjects with Alzheimer's disease (AD) may have low levels of circulating lactate and pyruvate but n...
In Alzheimer's disease (AD), the presence of amyloid-ii peptide may impair cell energy formation by ...
In Alzheimer's disease (AD), the presence of amyloid-ii peptide may impair cell energy formation by ...
Increasing evidence indicates that mitochondrial dysfunction occurs in the central nervous system as...
Increasing evidence indicates that mitochondrial dysfunction occurs in the central nervous system as...
Mitochondrial dysfunction is pivotal in the development of neurodegenerative dementias, causing cell...
Mitochondrial dysfunction is pivotal in the development of neurodegenerative dementias, causing cell...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
Mitochondrial dysfunction is pivotal in the development of neurodegenerative dementias, causing cell...
Mitochondrial dysfunction is pivotal in the development of neurodegenerative dementias, causing cell...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
It has been suggested that neuronal energy metabolism may be involved in Alzheimer's disease (AD). I...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by amyloid plaques that are co...